Xcout Intel
Valink Therapeutics
Valink Therapeutics Inc. is a biotechnology research company headquartered in Cambridge, Massachusetts, with a research and development subsidiary located in London, United Kingdom.
Subscribe to see Valink Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Valink Therapeutics at a glance
Valink Therapeutics is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $11.8M in October 2025. Xcout tracks 11 named people at Valink Therapeutics, including Arne Scheu (Co-founder and Chief Executive Officer).
Valink Therapeutics leadership
- Arne ScheuCo-founder and Chief Executive Officer
- Irsyad KhairilFounder
- George ProcopiouVP, ADC Chemistry & Engineering
- Jolyon MartinDirector of BD & Strategy
- Steven O ConnellDirector of Operations
- Arne ScheuCEO & Director
5 more named people on record for Valink Therapeutics, with roles, board committees and tenure — see the full roster →
Valink Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $11.8M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Valink Therapeutics competitors
A few of Valink Therapeutics's closest competitors — see the full list of competitors and alternatives →
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Apollo Therapeutics is a biopharmaceutical company with headquarters located in Cambridge, United Kingdom, alongside offices in Boston, Massachusetts. The company advances breakthrough science to build a portfolio of innovative therapeutics.
TRIMTECH Therapeutics is a biotechnology company headquartered in Cambridge, United Kingdom, focused on developing targeted protein degradation therapies like TRIMTAC and TRIMGLUE.
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Get Valink Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Valink Therapeutics in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access